Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
Matthew S McKinney, Anne W Beaven Division of Hematologic Malignancies, Department of Medicine, Duke University Medical Center, Durham, NC, USA Abstract: Most cases of indolent non-Hodgkin lymphoma (NHL) are incurable with standard chemoimmunotherapy approaches, and patients with relapsed/refracto...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2014
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b9627e99554348259522087327de8adb |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|